http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113398247-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113398247-B |
| titleOfInvention | Application of substance for promoting CD44 level in preparation of product for treating/preventing vascular endothelial inflammation by promoting CD44 |
| abstract | The application discloses application of a substance for promoting CD44 level in preparing a product for treating/preventing vascular endothelial inflammation by promoting CD 44. The application provided by the application inhibits the generation and development of vascular endothelial inflammation by promoting the CD44 level in a patient with vascular dermatitis, improves the condition of vascular endothelium of the patient, and has very important significance for reducing the morbidity of cardiovascular diseases, improving the prognosis of the patient, reducing the fatality rate of the patient and reducing the national medical cost. |
| priorityDate | 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 350.